A recent study using integrative genomic analysis demonstrated that in human ovarian cancer cells, ANGPTL4 is a direct target gene of Tafazzin (TAZ), which is another key transcriptional coactivator of the Hippo pathway32. Here, TAFAZZIN is linked to ovarian carcinoma.